This content has been developed by AstraZeneca in collaboration with Daiichi Sankyo. It is intended for healthcare professionals registered in Australia and is for educational purposes only and not intended for use for the diagnosis and treatment of individual patients. You can find and access scientifically balanced, evidence-based, and peer-led information and professional resources in support of HER2 IHC evaluation in breast cancer. The dissemination of this information may be subject to different medical and regulatory requirements in other countries. The company seeks no commitment from external stakeholders to take any action as a result of the resources provided.

Are you a healthcare professional practicing in Australia?